Last Updated on September 5, 2025 by Nyayik Vigyan
A recent social media controversy has thrust a health insurance Niva Bupa provider into the spotlight, raising critical questions about claim settlement practices in India’s insurance sector. The dispute centres around allegations that the company denied a substantial cashless claim for life-saving medical treatment, sparking widespread debate about the reliability of high-value health coverage.
The Controversy Unfolds
The dispute began when health insurance advisor Avigyan Mitra shared a LinkedIn post describing the case of Chandra Kumar Jain, a patient battling Myeloid Leukaemia who required urgent bone marrow transplant treatment at Sir HN Reliance Foundation Hospital in Mumbai. Despite holding a comprehensive policy worth ₹2.4 crore, the family faced significant challenges when seeking cashless approval for their medical expenses.
The case quickly gained traction on social media, with angel investor Udit Goenka calling health insurance “the biggest scam business in India”. The viral nature of the post highlighted growing consumer frustration with claim settlement processes in the insurance industry.
Niva Bupa Company’s Official Response
In response to the allegations, the Niva Bupa health insurance issued a detailed clarification stating that the claim had not been denied. According to their statement, they had already approved a ₹25 lakh pre-authorisation for Jain’s treatment, along with an additional ₹77,000. The company emphasised that “the originally approved ₹25 lakh pre-authorisation still stands valid, and the final claim will be settled at the time of discharge”.
The Niva Bupa insurer also revealed that Jain has been a policyholder since November 2021 and had already received ₹22.72 lakh from two prior claims in 2025. However, the company raised queries when treatment costs escalated dramatically from the initial ₹25 lakh estimate to ₹61 lakh, and subsequently to nearly ₹80 lakh by September 1.
Broader Industry Context
This controversy coincides with ongoing tensions between insurers and healthcare providers over pricing disputes. The company recently suspended cashless treatment facilities at all Max Hospitals across India from August 16, 2025, after failing to reach an agreement on tariff revisions. The contract between the two entities had expired in May 2025, with negotiations remaining deadlocked over pricing structures.
Max Healthcare countered that the insurer was demanding further tariff reductions from rates already pegged at 2022 levels, arguing that additional cuts would be “unviable and could compromise patient safety and the quality of care”. This standoff has left thousands of policyholders unable to access cashless treatment at Max’s network of 22 hospitals nationwide.
Customer Service and Support Systems
Despite the controversy, the Niva Bupa company maintains an extensive customer support infrastructure. Policyholders can access services through multiple channels, including the customer care helpline at 1860-500-8888, the company’s mobile app, and their online portal called “Insta Assist”. These platforms allow customers to check claim status, download policy documents, and track service requests.
The company’s login portal provides comprehensive self-service options, enabling policyholders to manage their policies, submit claims, and access health-related services. Through their digital platforms, customers can also initiate policy renewal processes and monitor their coverage details in real-time.
Market Performance and Investor Sentiment
The controversy has coincided with fluctuations in the company’s share price. Recent trading data shows the stock at ₹82.99, with a market capitalisation of ₹15,474 crores. The company’s IPO, which was launched in November 2024 with a price band of ₹70-74, initially saw moderate investor interest with subscription rates reaching 1.90 times.
The IPO GMP (Grey Market Premium) has shown volatility, reflecting market uncertainty about the company’s prospects amid ongoing controversies. Industry analysts continue to monitor how these operational challenges might impact long-term investor confidence.
Claims Processing and Settlement Practices
The Niva Bupa company’s approach to claim processing has come under scrutiny following this high-profile case. While they promote features like pre-authorisation within 30 minutes for active policies, critics argue that cost escalation disputes can create significant barriers for patients during medical emergencies.
Industry data reveals concerning trends in claim settlement ratios. The company’s incurred claims ratio stands at 59.92%, meaning that for every ₹100 claimed by policyholders, approximately ₹60 is paid on average. Additionally, the insurer ranks among the top 5 health insurers receiving the maximum policyholder complaints (1,770) for claim repudiation or rejection in FY2023-24.
Digital Innovation and Services
Despite challenges, the Niva Bupa company has invested heavily in digital infrastructure to improve customer experience. Their health app offers comprehensive services, including telemedicine consultations, diagnostic test bookings, and instant claim submissions. The platform also provides access to over 10,000 network hospitals for cashless treatment.
The Niva Bupa company’s OTC (Over-The-Counter) services have expanded to include WhatsApp support at 9811956696, allowing customers to access policy information and initiate service requests through familiar messaging platforms.
Partnership Networks and Coverage
The dispute with Max Hospitals has highlighted the importance of hospital network partnerships in health insurance. While cashless services remain suspended at Max facilities, the company continues to offer coverage through its extensive network of over 10,400 hospitals across India.
For patients requiring treatment at Max Hospitals, the insurer has implemented a priority reimbursement process, though this places the financial burden initially on policyholders. This arrangement underscores the challenges faced when hospital-insurer negotiations break down.
Future Implications and Industry Reform
This controversy has broader implications for India’s health insurance sector, where rising treatment costs often clash with insurer cost-control measures. The case has amplified calls for greater transparency in claim settlement processes and clearer communication between insurers and policyholders during medical emergencies.
Consumer advocacy groups are using this case to push for regulatory reforms that would provide better protection for policyholders, particularly in high-stakes medical situations. The Insurance Regulatory and Development Authority of India (IRDAI) faces pressure to strengthen oversight of claim settlement practices.
Customer Rights and Recourse
Policyholders facing similar situations have several avenues for recourse. The company’s grievance redressal mechanism includes escalation to senior management and ultimately to the Insurance Ombudsman if issues remain unresolved. The multi-tier complaint resolution process is designed to address policyholder concerns systematically.
For urgent medical situations, customers are advised to maintain detailed documentation of all communications with insurers and hospitals. This documentation becomes crucial if disputes escalate to formal grievance procedures or legal proceedings.
Conclusion
The controversy surrounding this ₹61 lakh claim dispute has exposed systemic challenges in India’s health insurance industry. While the insurer maintains that proper procedures were followed, the case highlights the delicate balance between cost control and patient care in life-threatening medical situations.
The outcome of the high-profile Niva Bupa case may influence future industry practices and regulatory approaches to claim settlement. For now, it serves as a stark reminder that despite comprehensive coverage and premium payments, policyholders may still face significant challenges when seeking treatment for critical medical conditions.
As the insurance industry continues evolving, transparency in claim processing, clearer communication during emergencies, and robust grievance mechanisms will be essential for maintaining public trust and ensuring that health insurance fulfils its fundamental promise of financial protection during medical crises.
Also Read:
